Metabolic Diseases  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT00409721: The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Completed
2
42
Canada
Memantine
University of Alberta, ALS Association
Amyotrophic Lateral Sclerosis
12/10
12/10
NCT00200538: Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

Completed
2
52
Europe
memantine
Nantes University Hospital
Dementia
 
 

Download Options